Applied Dna Sciences Inc financial data

Symbol
APDN on Nasdaq
Industry
Services-Testing Laboratories
Location
50 Health Sciences Drive, Stony Brook, NY
State of incorporation
DE
Fiscal year end
September 30
Former names
PROHEALTH MEDICAL TECHNOLOGIES INC (to 12/18/2002), DCC ACQUISITION CORP (to 5/4/2001), DATALINK CAPITAL CORP/TX/ (to 2/8/1999)
Latest financial report
10-Q - Q4 2024 - Feb 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 341 % +1.14%
Quick Ratio 16.4 % +45.7%
Debt-to-equity 61.5 % -49.8%
Return On Equity -102 % +7.83%
Return On Assets -62.4 % -26.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.3M shares +280%
Common Stock, Shares, Outstanding 54.1M shares +296%
Entity Public Float 5.7M USD -60.4%
Common Stock, Value, Issued 54.1K USD +294%
Weighted Average Number of Shares Outstanding, Basic 31.5M shares +4510%
Weighted Average Number of Shares Outstanding, Diluted 31.5M shares +4510%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 2.27M USD -59.6%
Research and Development Expense 3.67M USD -0.72%
Operating Income (Loss) -13.2M USD +2.39%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.63M USD -18%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -8.53M USD -18.3%
Earnings Per Share, Basic -0.65 USD/shares +96.1%
Earnings Per Share, Diluted -0.65 USD/shares +96.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.29M USD +177%
Accounts Receivable, after Allowance for Credit Loss, Current 912K USD +102%
Inventory, Net 469K USD +24.2%
Assets, Current 11.3M USD +146%
Property, Plant and Equipment, Net 638K USD +18.4%
Operating Lease, Right-of-Use Asset 607K USD -45.6%
Intangible Assets, Net (Excluding Goodwill) 2.7M USD 0%
Assets 16M USD +61.1%
Accounts Payable, Current 1.23M USD +21.3%
Contract with Customer, Liability, Current 217K USD +302%
Liabilities, Current 2.39M USD -7.78%
Contract with Customer, Liability, Noncurrent 194K USD -14.9%
Deferred Income Tax Liabilities, Net 684K USD 0%
Operating Lease, Liability, Noncurrent 48.9K USD -92%
Liabilities 3.42M USD -40.9%
Retained Earnings (Accumulated Deficit) -327M USD -7.77%
Stockholders' Equity Attributable to Parent 12.8M USD +201%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 12.5M USD +204%
Liabilities and Equity 16M USD +61.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.33M USD +11.5%
Net Cash Provided by (Used in) Financing Activities 6.31M USD
Net Cash Provided by (Used in) Investing Activities -117K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 54.1M shares +294%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.86M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10M USD +144%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 24.7M USD -20.2%
Deferred Tax Assets, Gross 24.9M USD -20.5%
Operating Lease, Liability 739K USD -40.3%
Payments to Acquire Property, Plant, and Equipment 117K USD
Lessee, Operating Lease, Liability, to be Paid 782K USD -42.9%
Property, Plant and Equipment, Gross 4.66M USD +9.69%
Operating Lease, Liability, Current 558K USD +9.49%
Lessee, Operating Lease, Liability, to be Paid, Year Two 195K USD -66.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 586K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 42.6K USD -67.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 195K USD
Deferred Tax Assets, Operating Loss Carryforwards 18.5M USD -26.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 58.6K USD -80.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%